PH vs SRPT · P/E 28, rev $19.85B vs rev $1.90B
Parker-Hannifin Corporation (PH) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
PH currently screens at market cap $91.89B and trailing P/E 27.7. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the PH and SRPT stock pages for the full models.
Not investment advice.